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Severe burn injuries can lead to delay in healing and devastating scar formation. Attempts are 
made to develop a suitable skin substitute for scarless healing of such skin wounds.  Currently, 
there is no effective strategy yet for a complete scarless healing after the thermal injuries. In our 
recent work we fabricate and evaluated a 3D protein-based artificial skin made from 
decellularized human amniotic membrane (AM) and electrospun nanofibrous silk fibroin (ESF) 
in vitro. We also characterize both biophysical and cell culture investigation to establish in vitro 
performance of the developed bilayer scaffolds. In this report we evaluate finally about the 
appropriate utility of this fabricated bi-layered artificial skin in vivo with particular reference to 
healing and scar formation due to biochemical and biomechanical complexities of the skin. For 
this work. AM, AM/ESF alone or seeded with adipose tissue-derived mesenchymal stem cells 
(AT-MSCs) are implanted to full thickness burn wounds in mice. The healing efficacy and scar 
formation are evaluated at 7, 14 and 28 days post-implantation in vivo. Our data reveal that ESF 
accelerates wound healing process through early recruitment of inflammatory cells such as 
macrophages into the defective site, as well as up-regulation of angiogenic factors from the AT-
MSCs and facilitation of remodeling phase. In vivo application of the prepared AM/ESF 
membrane seeded with the AT-MSCs reduces significantly the post-burn scars. The in vivo data 
suggest that the potential applications of the AM/ESF bi-layered artificial skin may be 
considered as a clinically translational product with stem cells to guide scarless healing of sever 
burn injuries.  
Keywords: human amniotic membrane; silk fibroin; electrospinning; artificial skin; wound 
healing; scar. 
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Burn injuries are among the most devastating of all injuries and present a major global public 
health crisis 1, 2. Lack of an appropriate burn care strategy and delayed treatment pose a great 
threat to human health and life 3. While in high-income countries burn death rates are on a 
decline, the direct costs for care of children with burns in the United States of America exceeded 
US$ 211 million in 2011. Moreover, in low-income countries such as India over 1 000 000 
people are moderately or severely burnt every year 4. It is well documented that 3rd degree burn 
wounds require skin grafting to accelerate wound healing and prevent post-burn infections.  This 
subsequently results in scarless healing of the wound 5, 6. Many efforts are made to develop skin 
substitutes, some of which are already used in clinical practices (SI Table 1). However, the 
challenges in total skin reconstruction with complete function, especially in 3rd degree burn 
injuries treatment, remain a major concern at burn intensive care units 5, 7-9. An ideal tissue-
engineered skin substitute should be biocompatible, biodegradable, impermeable to external 
bacteria, prevent dehydration, have a degradation rate comparable to the healing process, have a 
rapid and sustained adherence to the wound surface, have an inner surface structure to allow for 
cell migration/proliferation/in-growth of new tissue and be flexible and pliable so it can conform 
to irregular wound surfaces. Moreover, a skin substitute should be readily available, 
reproducible, cost-effective and require minimal storage requirements 7, 10, 11. 
In our recent report, we fabricate a 3D protein-based bi-layered artificial skin made from 
decellularized human amniotic membrane (AM) and electrospun nanofibrous silk fibroin (ESF). 
We characterize in detail the mechanical and biological properties of this bi-layered in vitro for 
skin tissue engineering applications 12. The effects of the AM/ESF on secretion of angiogenesis 
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factors from adipose tissue-derived mesenchymal stem cells (AT-MSCs) are also investigated in 
vitro. 
In this work, we hypothesize that the above fabricated 3D protein-based bilayer artificial skin 
alone and in combination with adipose tissue-derived mesenchymal stem cells (AT-MSCs) may 
have a promising impact on angiogenesis and scarless healing of 3rd degree burn wounds in 
BALB/c mice. This idea of utilization of the engineered bi-layer artificial skin is based on our in 
vitro observations. This throws information about the maintenance of efficacy when the 
engineered matrix/scaffold is translated from in vitro to in vivo behaviors. This report describes 
the angiogenesis and scarless healing effects of the AM/ESF bi-layered artificial skin in vivo in 
mice burn wound model. The results of this experimentation clearly indicate that the engineered 
blend matrices of this type may be used for quick recovery of deed burn injuries and finally to 
obtain scarless healing. 
 
2. MATERIALS AND METHODS 
2.1. Preparation of decellularized human amniotic membrane/electrospun nanofibrous silk 
fibroin (AM/ESF) 
The AM/ESF bi-layered 3D artificial skin was prepared and fully characterized in vitro in our 
recent investigation 12. Briefly,  the AM samples were collected and denuded by a simple and 
cost-effective method described previously 13. After confirmation of the full removal of the cells 
and cells’ fragments, AM was covered with ESF with average diameter of 93 ± 25 nm by 
electrospinning. The AM/ESF membrane was embedded in 70% ethanol for 1 h to determine the 
molecular conformation of the SF 14. After embedding in ethanol, ESF was tightly coated to AM 
Page 5 of 48
































































and was not separable. The AM/ESF 3D bi-layered artificial skin was cyto-biocompatible with 
favorable biomechanical property and angiogenic effects when seeded with AT-MSCs in vitro 12. 
 
2.2. In vivo study  
2.2.1. Animals 
BALB/c male mouse (weighing 16–19 g) were purchased from Pasteur Institute of Iran and then 
acclimatized in an animal facility under standard conditions for one week prior to use. The 
surgery was performed according to the 8th edition of the "Guide for the Care and Use of 
Laboratory Animals" 15.  
 
2.2.2. Experimental thermal injury 
The animals were subjected to 3rd degree round skin burns (1 cm in diameter) by brass probe as 
described  previously 16 with minor modification. The animals were anesthetized with an IP 
injection of ketamine hydrochloride (100 mg.kg −1) and xylazine (10 mg.kg −1) (both from 
Sigma, USA) and placed in prone position on a surgical frame. The dorsal surface of mice was 
shaved and sterilized using 70% ethanol. The heated metal sheet (100 ºC) was placed on mice’s 
dorsum for 10s with no external pressure to induce consistent 3rd degree burn injuries. The 3rd 
degree burn wound was confirmed by histological analyses (Fig. 1c). Two identical burn wounds 
were produced (left and right sites of the dorsum) for each mouse.  
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2.2.3. Grafting procedure    
The animals were randomly divided into following five experimental groups:  
G1 - controls with 3rd degree burn wound and no implantation (No treated wound, NTW), 
(negative control (n=15)); G2 - 3rd degree burn wound implanted with AM alone (n=15); G3 - 3rd 
degree burn wound implanted with AT-MSCs and AM (AM/AT-MSCs) construct (n=15); G4 - 
3rd degree burn wound implanted with AM/ESF alone (n=15), and G5 - 3rd degree burn wound 
implanted with AT-MSCs and AM/ESF (AM/ESF/AT-MSCs) construct (n=15). For 
experimental groups G3 and G5, 1  104 AT-MSCs were cultured on the membranes for 72 
hours prior to implantation. The AT-MSCs were isolated from inguinal fat pads of BALB/c mice 
and fully characterized by flow cytometry (for CD34, CD44, CD45, CD73, CD90 and CD105) 
and differentiation capacity toward osteogenic and adipogenic lineages in in vitro by a protocol 
described in details in in vitro part of this study published elsewhere 12. The cells harvested from 
second passage were used in this study. For grafting, the post-burning necrotic tissue was 
cleaned. After debridement, the membranes were placed on the wounds of G2-G5 experimental 
groups. In G1 group, the wounds were left with no treatment method. The membranes were well 
adhered to wound bed during 3-4 min post grafting with no suturing. No membrane detachment 
was observed during the 28 days period. Each wounds only received one membrane after 
debridement with no graft changing during the interval time points. In it noted that two wounds 
of each mouse were treated by the same method to avoid systemically effects of one wound to 
another near wound 17. For example in G5, both wounds were implanted with AM/ESF-AT-
MSCs construct. The wound healings were studied by macroscopic observations, histological 
examinations and RT-PCR. The burn wound model and grafting are illustrated in Figure 1. 
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Figure 1. Summarized schematic of the current study. (a) Creation of the 3rd degree burn wounds 
(step 1 to 6), (b) representation of the 3rd degree burn, (c) H&E sample depicting 3rd degree burn 
wound (d) generation of the burn wound including re-epithelialization and wound healing cells 
recruitment. (Yellow arrows indicate the direction of re-epithelialization). AT-MSCs: Adipose-
derived stem cells; BC: Blood clot; ECs: Epithelial cells; AM: Human amniotic membrane; 
AM/ESF: Amniotic membrane/Electrospun silk fibroin; HF: Hair follicle; KCs: Keratinocyte 
cells; MQ: Macrophage; MSCs: Mesenchymal stem cells; ESF: Nanofibrous silk fibroin; PMN: 
Polymorphonuclear leukocytes. 
 
2.2.4. Macroscopic observations  
The burn wounds were photographed at days 0, 4, 7, 14 and 28 post-implantation and the wound 
sizes were recorded 18. The wound closure for each time interval was determined by the 
following formula (Equation 1): 
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2.2.5. Histological examinations 
The animals were sacrificed on days 7, 14 and 28 days post-implantation. Tissues were collected 
for histological evaluations. For each time point, five mice were sacrificed from each group. The 
burn wound tissue including the wound bed and healthy skin surrounding the wound were 
collected and fixed with 10% neutral buffered formalin at room temperature for 48 h. The 
samples were dehydrated by ethanol, embedded in paraffin blocks and sectioned at 4 µm 
thickness slices 13. The sections were stained with Hematoxilin & Eosin (H&E), Masson’s 
trichrome and immunohistochemistry. Five sections were taken from each paraffin block. For 
each subsequent measurement, 10 non-overlapping microscopic field-of-views were chosen 
including 5 fields at the edges and 5 fields at the center of the wound. The H&E stained sections 
were investigated for wound healing, re-epithelialization and formation of new hair follicles, scar 
elevation index (SEI) and epidermal thickness index (ETI). Masson’s trichrome stained sections 
were used to determine the collagen accumulation. Immunohistochemistry was performed to 
evaluate angiogenesis, wound healing and scar formation. All counts and scoring were 
performed independently by three blind observers. 
 
2.2.5.1. Wound healing scoring 
The wound healing response in H&E stained samples was scored according to a method 
published elsewhere 19, 20. The scoring was as follows: “0” represented none to minimal cell 
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accumulation and granulation tissue; “1” represented thin and immature granulation dominated 
by inflammatory cells but with few fibroblasts; “2” depicted moderately thick granulation tissue, 
ranging from being dominated by inflammatory cells to more fibroblasts and collagen 
deposition, extensive neovascularization; “3” constituted thick, vascular granulation tissue 
dominated by fibroblasts and extensive collagen deposition; and “4” amounted to fully healed 
wound.  
 
2.2.5.2 Hair follicles formation 
The average number of the hair follicles (HF) formed in the burned areas was determined in 
H&E-stained sections 16. The average number of hair follicles within ten fields of H&E stained 
sections (five fields from center and five fields from margins of wound) was counted for each 
experimental group.  
 
2.2.5.3. Scar elevation index (SEI) 
The H&E stained samples were viewed at 100 magnification and the SEI was determined 
(n=5) for histomorphometric analysis as described elsewhere 21, 22. The SEI was defined by the 
following formula (Equation 2): 
!"# = $%		&%                                                    (Equation 2) 
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Where TWD and ND indicate the height of total dermis wound and height of normal underlying 
dermis (defined based on the height of the adjacent normal dermis), respectively. The SEI of 1 
and > 1 represent scarless wound healing and scar formation, respectively. 
 
2.2.5.4. Epidermal thickness index (ETI) 
The H&E stained sections were observed under light microscope (Olympus BX51, Olympus, 
Tokyo, Japan) at 400 magnification and the average thickness of the epidermis across the five 
fields of scar tissue was measured to calculate the ETI defined by the epidermal hypertrophy 
degree. The ETI was defined based on a formula (Equation 3) described by Rahmani-
Neishaboor et al. 22: 
"'# =  ()(	*	+,		,-	,,()(	*	+,		.	/	,0                                                               (Equation 3) 
The epidermal thickness from five fields of uninjured skin was also measured from both sides of 
the scar tissue 22. The ETI of 1 and > 1 indicate fully healing of wound without scar formation 
and newly formed hypertrophied epidermis, respectively. 
 
2.2.5.5. Masson’s Trichrome  
The sections collected from days 7, 14 and 28 were stained with Masson’s trichrome and viewed 
under light microscope (Olympus BH-2, Japan) for the assessment of collagen content and 
maturation within the dermis. The collagen deposition was scored from grade 0 (lowest collagen 
density) to grade 4 (highest collagenesis).  
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The expressions and densities of collagen types I, III and IV (Col I, III and IV) at day 28, CD31 
(PECAM-1) at days 14 and 28, and VEGFa1 and VEGFR2 at days 7, 14 and 28 were studied by 
immunohistochemistry 21, 23, 24. The paraffin-embedded sections were re-hydrated through a 
graded series of ethanol and the endogenous peroxidase was inactivated by 3% H2O2. The 
antigen retrieval was performed by heating method using an autoclave. After blocking the 
nonspecific binding sites with 5% bovine serum albumin (BSA) for 1h, the samples were 
incubated with primary antibodies against Col I, III, IV, CD31, VEGFa1 and VEGFR2 (all 
purchased from Abcam, Cambridge, MA, USA) at 4 ºC. The sections were then treated with anti-
rabbit/anti-mouse Envision (Dako, Denmark) as a secondary antibody for 30 min. The samples 
were visualized by incubation with a 3,3΄-diaminobenzidine (DAB) solution as substrate and 
viewed under light microscope (Olympus BX51, Olympus, Tokyo, Japan) at 100 
magnification 25. Weidner’s method was used for determination of micro-vessel density (MVD) 
using CD31 expression 21. For this, the most vascularized areas within the CD31 immuno-stained 
samples of each experimental group were selected at 100 magnification and the microvessels 
(vessels with distinct lumens) were counted within each selected area at 200 magnification. 
The MVD values were reported as the average count of microvessels in three high vascularized 
areas. All the scoring and counts were performed by three independent observers blinded to the 
experimental setup.  
 
2.2.5.7. Real-time PCR 
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The tissue samples (50 mg) were harvested at days 7, 14 and 28 post-implantation and the total 
RNA was extracted using an RNeasy Mini Kit (Cinagen, Tehran, Iran) following the Supplier’s 
instructions. The full thickness skin tissue away from the implantation site served as control and 
coded as “normal skin” (NS). In brief, the samples were trimmed of excessive surrounding 
tissue, cut into small pieces and lysed with lysing buffer. The cDNA was synthesized using 
random hexamer primers by a High-Capacity cDNA Archive kit (Applied Biosystems, Foster 
City, CA, USA) following the Supplier’s instructions. The relative transcript levels of Collagen 
type I, Collagen type III, Collagen type IV, TNFα, TGF-β1, MIP-2, IL-1b, bFGF, VEGF-α1, 
VEGF-R2, MMP-1 and MMP-2 were determined by rotor-gene 6000 (Corbett Life Science, 
Sydney, Australia) instrument using PCR Master Mix (TaKaRa, Dalian, China). The conditions 
of the reactions were as follows: 95 ºC for 10 min followed by 40 cycles of 95 ºC for 15 s, 60 ºC 
for 30 s, 72 ºC for 30 s. The Ct value for each sample was defined. Relative transcript level for 
each target gene was normalized against beta actin (b-actin) as housekeeping gene. The relative 
expression level fold was defined using 2-∆∆Ct. Tissue samples harvested from areas with no 
wounds served as negative controls. All primers used in this study and the product lengths are 
listed in SI Table 2. 
 
3. RESULTS AND DISCUSSION 
3.1. In vivo observations 
3.1.1. Macroscopic observation and wound closure 
The photographs of the wounds at 0, 4, 7, 14 and 28 days post-wounding are shown in Figure 
2a.  As anticipated, there was a significant difference in wound contraction between the 
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implanted experimental groups (G2-5) and NTW (G1). Almost all the wound areas were re-
epithelialized in groups G3-G5 at day 14. The recorded wound sizes and the percentage of 
wound closure were determined and compared between all experimental groups (Figure 2b). 
The early wound closure is of the most crucial parameters in treatment of wounds, especially the 
extensive ones. Silk protein was found to enhance the wound closure and improve healing 26. As 
shown in Figure 2, there was a significant difference between the wound closure levels in the 
animals implanted with AM/ESF/AT-MSCs when compared to those with the animals implanted 
with AM/AT-MSCs on days 7, 14 and 28 post-surgery (‡p≤0.05). This suggests that the seeded 
mesenchymal stem cells had an important effect on proliferation, migration and differentiation. 
Moreover, the wound sizes in the animals treated with AM/ESF were significantly smaller when 
compared to those treated with AM on day 14 and 28 (†p≤0.05). The wound sizes showed 
statistically significant decrease in all the implanted animal groups in comparison with the NTW 
group (G1) on days 7, 14 and 28. The presence of ESF had a profound effect in wound healing 
acceleration when compared to the AM only. The positive effects of the ESF in wound 
acceleration were reported by others 27-29.  
Page 14 of 48

































































Page 15 of 48
































































Figure 2. Macroscopic observations and wound closure. (a) The photographs of wounds in 
BALB/c mice in which the wounds received implantation of AM (G2), AM/AT-MSCs (G3), 
AM/ESF (G4) and AM/ESF/AT-MSCs (G5). The animal with burn wound and no implantation 
served as control group (NTW, G1). Representative photographs of the wounds were taken at 0, 
4, 7, 14 and 28 days post-wounding. (b) Percentage of wound closure in all experimental groups 
at 0, 4, 7, 14 and 28 days post-wounding. †† statistically significant difference with the NTW 
group (G1); † statistically significant difference with the animals received AM (G2); ‡ 
statistically significant difference with the animals received the same implant without AT-MSCs 
(G2). The data are analyzed using one-way ANOVA (post hoc: LSD), as p≤0.05 is considered as 
level of significance. Each bar represents mean ± SD. 
 
3.1.2. Histological examinations 
3.1.2.1. H&E 
The photographs of the H&E sections are shown in Figure 3a. At day 7 post-wounding, the re-
epithelialization began from the margins of the wound. In addition, infiltration of the PMN and 
neutrophils was clearly observed in all experimental groups. The amount of acute inflammatory 
cells in the wound area of the NTW group was very low when compared to other experimental 
groups. The stretch of the membrane over the underlying muscle tissue is clearly visible. The 
granulation as well as deposition of extra-cellular matrix elements in the animals receiving 
implants was obviously higher than that in NTW group (G1). No hair follicles were observed 
within the burned area (Figure 3c). The histological score of the AM/ESF/AT-MSCs treated 
animals was significantly higher than other experimental groups at day 7 (p<0.01). At this point 
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of time, the healing in all the implanted animals (G2-4) were better than NTW (p<0.05) (Figure 
3b). 
On day 14, all the surfaces of the wound were occupied by the epidermis layer. The newly 
formed granulation tissue was continued to be thicker and the cells were well penetrated into the 
wound site. At that time, hair follicle formation is clearly observed in margins of the wounds. 
Granulation and cellularity in G4 and G5 was higher than in the G2 and G3, respectively. In 
experimental groups G3-G5, the healing was followed by the maturation of the granulation tissue 
(Figure 3a). After 14 days post-operation, the difference between the healing scores of the 
experimental groups (G3-5) was significantly higher than those in NTW animals (p<0.01) 
(Figure 3b). 
At 28 days post-implantation, the wounds in G1 and G2 remained unhealed, while almost all the 
wound areas were healed in other experimental groups (Figure 3a). The structure and 
appearance of the skin tissue in the middle of the defect was closely similar to the normal skin 
(NS) in G5. Hair follicles were appeared in the middle of the AM/ESF/AT-MSCs-treated 
wounds. With maturation of granulation tissues, the cellularity in the defect sites of the animals 
receiving the AM/AT-MSCs, AM/ESF and AM/ESF/AT-MSCs was profoundly decreased 
(Figure 3a). The histological observations of the H&E stained-sections revealed the positive 
effects of the ESF-covered AM and also the presence of AT-MSCs in promotion of skin tissue 
healing. In a separate study, AT-MSCs were seeded on silk fibroin/chitosan (SF/CS) and then 
implanted in Murine Soft Tissue Injury Model 30. A significant acceleration in wound healing of 
AT-MSCs-silk fibroin/chitosan receiving wounds was observed when compared to untreated 
animals or treated with SF/chitosan. The effects of SF on skin wound healing was further showed 
by Shefa et al. 31. They fabricated an oxidized cellulose nanofiber-SF porous scaffold and 
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showed that this scaffold had superior in vitro and in vivo characteristics for critical sized rat skin 
excisional wound healing compared to oxidized cellulose nanofiber alone. 
Our results show that both SF and AT-MSCs remarkably accelerate burn wound healing through 
early re-epithelialization and ECM formation. At day 28, the wound healing scores in the 
AM/ESF receiving animals was significantly higher than AM alone. Moreover, all the treated 
animals had a significantly accelerated wound healing score in comparison to the NTW group 
(p<0.05) (Figure 3a). 
The average number of the newly formed hair follicles in the wounds implanted with AM/ESF 
and AM/ESF/AT-MSCs was significantly higher than those in AM and AM/AT-MSCs at days 
14 and 28 (p<0.05). This indicates the favorable effects of both ESF and AT-MSCs on formation 
of hair follicle. Furthermore, there was no significant difference between mean numbers of 
newly formed hair follicle in AM/ESF/AT-MSCs implanted wound (G5) and NTW (G1). It is 
reported that the formation of new hair follicles was not required for a complete healing of skin 
wounds. This may significantly accelerate the healing process 22, 32. 
The histological data of the current study were in agreement  with other investigations, which 
used mesenchymal stem cells and silk fibroin in skin tissue regeneration 27, 33, 34. For instance, 
bone marrow-derived mesenchymal stem cells enhanced skin wound healing though 
differentiation and angiogenesis 27.  According to other reports, silk fibroin protein secretes 
specific growth factors, which aid wound healing. SF enhance wound healing through 
differentiation and proliferation of mesenchymal stem cells and therefore facilitate wound 
healing 30, 35, 36. 
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Figure 3. Histological observations. (a) Hematoxylin and eosin stained samples at days 7, 14 and 
28 post-surgery.  (b) Wound healing scoring and (c) mean hair follicle formation. D: Dermis; M: 
Muscle; AML: Amniotic membrane layer; NS: Newly formed skin. Insert: Unwounded skin. 
Black and yellow arrows indicate outer surface of skin and epidermis layer, respectively. ‡ 
indicates significant difference with G3; † indicates significant difference with G2; †† indicates 
significant difference with G1 (NTW) (p<0.05).  
 
3.1.2.2. Collagen synthesis and density  
Page 19 of 48
































































Collagen deposition within the burned tissues at days 7, 14 and 28 post-implantation was 
determined by Masson’s trichrome staining. Collagen and cell nuclei were stained in blue/green 
and dark blue, respectively (Figure 4a). On day 7, the collagen deposition in the wounds treated 
with AM/ESF/AT-MSCs was much higher than other experimental groups. After 14 days, the 
NTW control and AM implanted animals showed highest collagen deposition compared with 
other groups. Collagen density in the NTW control and AM remained high at day 28 post-
surgery, while the wounds treated with AM/AT-MSCs, AM/ESF and AM/ESF/AT-MSCs were 
similar to that in NTW (Figures 4a and insert). All the Masson’s trichrome stained samples 
indicated that both ESF and AT-MSCs significantly accelerated wound healing. As shown in 
Figure 4a the wounds treated with AM/ESF/AT-MSCs healed almost completely on day 28. To 
confirm the results obtained from Masson’s trichrome staining, the relative expressions of 
collagen types I, III and IV at days 7, 14 and 28 post-operation were determined by RT-PCR.  
The results were compared among all the experimental groups (Figure 4b). The results 
confirmed that all the treated groups, especially AM/ESF and AM/ESF/AT-MSCs, exhibited 
change in collagen type from COL III to COL I by day 14. This suggests that wound healing was 
accelerated in these experimental groups. In a study by Shan et al. 20 the silk fibroin/gelatin 
nanofibrous skin dressing promoted the burn wound healing by regulating newly formed 
collagens and improving collagen organization. Our results are consistent with other relevant 
studies 20, 33, 37-39. 
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Figure 4. Determination of collagenesis. (a) Masson’s trichrome staining of the different 
samples at days 7, 14 and 28 post-operation. (b) Collagen deposition scoring, relative expression 
of COL I, III and IV at 7, 14 and 28 days after post-operation. The expression results was 
normalized to that in normal skin. Relative expression of MIP2, TNFα and TGFβ1 in defect 
tissue of animals at 7, 14 and 28 days after post-implantation. The expression results are 
normalized to that of normal skin. D: Dermis; M: Muscle; NS: Newly formed skin. Insert: 
Unwounded skin stained with Masson’s trichrome. Black triangle and yellow arrow indicate 
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outer surface of skin and Epidermis layer, respectively. ‡ indicates significant difference with 
G3; † indicates significant difference with G2; †† indicates significant difference with G1 
(NTW) (p<0.05). 
 
3.1.2.3. Localized inflammatory response 
The relative expressions of MIP2, TNFα1 and TGFβ1 at 7, 14 and 28 days of post-implantation 
were determined by RT-PCR to verify whether the implanted membrane stimulates any 
inflammatory reactions. The results are shown in Figure 4b. TNF-α is secreted by various cell 
types, especially activated macrophages. It is activated in acute phase inflammation through 
regulation of inflammatory cells. TGF-β1 is secreted by many cell types, especially leucocytes 8, 
40, 41. TGF-β1 promotes wound healing through regulation of cell growth, migration, 
differentiation and apoptosis 8, 42. MIP2 (called also chemokine (C-X-C motif) ligand 2) is 
secreted by monocytes and macrophages. This cytokine is a chemoattractant for PMN and causes 
localized inflammatory reactions 8, 43. According to our results, all the analyzed cytokines were 
significantly upregulated in all animals with implanted wounds compared to NTW control at day 
7 (p≤0.05). At the same time, an increased expression level of these cytokines in the AM/ESF 
and AM/ESF/AT-MSCs treated wounds was observed in comparison with other experimental 
groups. At day 14, TGF-β1 remained upregulated in all treated wounds, while MIP2, TNFα1 
were significantly down-regulated when compared to NTW group (p≤0.05). The MIP2, TNFα1 
and TGFβ1 gene expression levels were returned to normal level in all treated wounds by day 28. 
These results apparently revealed that the inflammatory response was not completely eliminated 
in NTW group event by day 28. A possible explanation of this is that the ESF accelerate wound 
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healing through inciting the acute phase immune response (PMN) and recruitment of 
macrophages into defect site during the first days of implantation. We also observed an 
immunomodulatory activity of the AT-MSCs at day 14 of post-operation.  
 
3.2.3. Vascularization 
Neovascularization is an essential step in obtaining successful healing of a wounded skin. 
Delayed neovascularization often leads to delayed wound healing and  formation of a fibrotic 
tissue causing  a significant  drawback when it comes to the available skin substitutes today 44, 45. 
Earlier, we found that AM/ESF up-regulate the expression of angiogenic factors such as 
VEGFa1 and bFGF in AT-MSCs in vitro 12. To evaluate the effects of ESF and AT-MSCs on 
promoting neovascularization in vivo, the expression and localization of VEGFa1, VEGFR2 and 
CD31 were determined by immunohistochemistry and scoring analyses (Figures 5 and 9). 
VEGFa is one of the most important angiogenesis factors. It promotes angiogenesis by acting on 
endothelial cells 8, 46, 47 via VEGFR2 that is highly expressed  on these cells 48, 49. The 
Immunohistochemistry results of the VEGFa and VEGFR2 are depicted in Figures 5a, 5b and 6. 
At post-operation day 7, the expressions of VEGFa1 and VEGFR2 in all the treated experimental 
wounds were higher than that in NTW group. At this time, the expression of these factors in the 
wounds treated with AM/ESF and AM/ESF/AT-MSCs was much higher than in other 
experimental groups. At day 28 post-operation, the expressions of VEGFa and VEGFR2 were 
profoundly down-regulated in all treated groups compared to NTW group. Li et al 50 fabricated a 
strontium loaded SF/sodium alginate film with high cytocompatibility and proangiogenesis 
action for skin wound healing applications. They showed that loading strontium to SF blend 
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increased secretion of VEGF and bFGF form L929 fibroblasts in vitro and may successfully 
promote neo-vascularization in wound bed.     
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Figure 5. Neovascularization assay. a) Immunohistochemistry staining of VEGFa and (b) 
VEGFR2 at 7, 14 and 28 days of post-operation. The black arrows indicate VEGFa and 
VEGFR2. NTW (wound with no implantation).  
 
 
Figure 6. RT-PCR results of relative expressions of IL1b, bFGF, VEGFa and VEGFR2 at 7, 14 
and 28 days of post-operation. ‡ indicates significant difference with G3; † indicates significant 
difference with G2; †† indicates significant difference with G1 (NTW). NTW (wound with no 
implantation); NS (normal skin). 
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The expression of CD31, a specific marker of endothelial cells of early blood vessels, was also 
evaluated by immunohistochemistry to determine the microvascular density (MVD) within 
wound sites 21, 51. The values of immunohistochemistry results of CD31 and MVD are shown in 
Figures 7a and 7b, respectively. At day 7, no blood vessels were observed in any of the wounds. 
At 14 days of post-operation, the MVD values in all the treated wounds were much higher than 
in NTW group. The wounds treated with AM/AT-MSCs, AM/ESF and AM/ESF/AT-MSCs 
showed the highest MVD value compared to other experimental groups. This suggests that the 
neovascularization greatly was accelerated during this time interval. At post-implantation day 28, 
the wounds treated with AM/AT-MSCs, AM/ESF and AM/ESF/AT-MSCs showed the highest 
MVD values compared to other groups.  
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Figure 7. Determination of microvessel density (MVD). (a) Immunohistochemistry staining of 
CD31 (PECAM-1) at 14 and 28 days of post-operation. (b) MDV of each experimental group on 
post-operation 7, 14 and 28 days. The yellow arrow indicates micvrovessel. NTW (wound with 
no implantation); NS (normal skin). ‡ indicates significant difference with G3; † indicates 
significant difference with G2; †† indicates significant difference with G1 (NTW). 
 
We used RT-PCR to study the neovascularization rate in defect site by determining the relative 
expressions of IL-1β, FGF, VEGFa and VEGFR2, the most important factors involved in 
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angiogenesis 52-54. VEGFa is primarily secreted by mesenchymal stem cells 55. IL-1β is mostly 
secreted by activated macrophages 54, 56. The relative expressions of the mentioned angiogenic 
factors were compared with those in normal skin. The results showed that the relative expression 
of all the examined angiogenic factors were up-regulated in all treated wounds compared to 
NTW group on days 7 and 14 post-operation. The rate of up-regulation was significantly higher 
in AM/ESF and AM/AT-MSCs treated wounds groups when compared to other groups. At day 
28, the relative expressions of these factors in all treated wounds were significantly down-
regulated compared to NTW group.  The relative expressions of VEGFa and IL-1β returned to 
that of the levels detected in normal skin were observed.  
The SF is an excellent supporter for endothelial cell proliferation, attachment, migration, 
differentiation and formation of microvessel-like structure 57-62. Furthermore, the involvement of 
mesenchymal stem cells in promotion of neovascularization is widely reported 27, 63, 64. For 
instance, Shan et al. 20 showed that the silk fibroin/gelatin nanofibrous bio-scaffold promoted the 
burn wound healing process by accelerating angiogenesis. The data obtained from this study 
indicate that ESF has a great potential in tissue engineering by promoting wound healing process 
through the increased secretion of angiogenesis factors from AT-MSCs and acceleration of early 
neovascularization. 
 
3.2.4. Scar formation 
The samples harvested from day 28 of post-implantation were examined for scar formation. . The 
samples were measured for collagen deposition, SEI, ETI, gene expression profile of Col I, Co 
III, Col IV, MIP-2, TGFβ1, TNFα1, MMP-1 and MMP-2.  
Page 28 of 48

































































3.2.4.1. Re-epithelialization and collagen deposition 
Abnormally excessive collagen deposition in defect site is the most important indicator of scar. 
The late re-epithelialization and infection increase cellularity within the 3rd degree wounds, 
retain collagen synthesis, postpone collagen remodeling, and subsequently the accumulation of 
irregular collagen fibers stimulate scar formation 5, 65, 66. The collagen deposition and relative 
collagen density on day 28 are presented in SI Figures 1a and 1b. The results obtained from 
Masson’s trichrome staining indicated that the collagen density in the wound treated with 
AM/ESF/AT-MSCs (G5) was reduced. The morphology of the fibers was similar to the normal 
skin and required more time to complete remodeling. This result is in agreement with earlier 
report that showed the anti-scarring effects of astragaloside IV-functionalized silk fibroin/gelatin 
electrospun nanofibrous scaffold 20. It was also reported that the matrices used as skin dressing 
material promoted scarless healing of deep partial-thickness burn wound by improving collagen 
organization. In a study conducted by Acharya et al. 67, SF was successfully conjugated with 
lactose in two 2D and 3D scaffold forms to prevent scar formation through suppression of 
fibroblast differentiation into contractile myofibroblasts. Their results showed that lactose-
conjugated SF scaffold has superior cell adhesion property for fibroblasts than myofibroblasts 
compared to pure SF. Myofibroblasts lost their contractile phenotype when cultured on lactose-
conjugated SF compared to SF alone.  
Our histological observations showed that re-epithelialization in experimental groups G3, G4 and 
G5 were >95%, >90% and 100%, respectively (SI Figure 1b). All the results revealed positive 
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effects of both ESF and mesenchymal stem cells on wound healing, re-epithelialization and 
prevention of scar that are consistent with earlier studies 18, 27, 68.  
 
3.2.4.2. Scar elevation index (SEI) 
Scar elevation index results are presented in SI Figure 1b. The wounds showed various rates of 
scar in all experimental groups. NTW exhibited the highest mean SEI (2.9 ± 0.45) compared to 
treated wounds (p<0.05). SEI for the wounds treated with AM and AM/ESF was 2.1 ± 0.35 and 
1.6 ± 0.31, respectively (p<0.05). Additionally, the wounds implanted with AM/AT-MSCs and 
AM/ESF/AT-MSCs had a SEI of 1.5 ± 0.22 and 1.1 ± 0.12, respectively (p<0.05). The smaller 
SEI value represents lower scar formation. Normal skin has a SEI of 1. Significantly reduced SEI 
values in our experiments indicate a clear reduction of scar in the treated wounds compared to 
negative controls (NTW). The addition of ESF and AT-MSCs further reduced scar formation by 
decreasing the thickness of the epidermis. Reduced SEI by other biodegradable scaffolds were 
reported earlier 21, 22. Cheng et al. 21 functionalized the ginsenoside-Rg3-loaded fibrous with 
bFGF growth factor. They observed that the resulted bio-functionalized scaffold reduced SEI in 
rabbit ear model full thickness wounds. The evidences obtained from SEI results of our study 
reveal that the silk fibroin nanofibers may reduce scar formation through decrease of dermis 
proliferation. 
 
3.2.4.3. Epidermal thickness index (ETI) 
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Epidermal thickness index for all the wounds was measured at 28 days of post-operation and the 
results are illustrated in SI Figure 1b. The NTW group showed the highest ETI (4.3 ± 0.63 time 
greater than normal skin) compared to the treated animals’ wounds (p<0.05). ETI for the wound 
treated with AM, AM/AT-MSCs, AM/ESF and AM/ESF/AT-MSCs was 3.2 ± 0.72, 2.1 ± 0.41, 
1.9 ± 0.43 and 1.1 ± 0.15, respectively. Our ETI results for a combination of AM and ESF 
treatment decreased significantly scar formation (p<0.05). This combinatorial approach of both 
AM membrane, ESF and mesenchymal stem cells yielded superior results. This greatly inhibits 
scar formation (p<0.05). Less epidermal proliferation in the wounds treated with nanofibrous 
scaffolds and anti-inflammatory factors were reported elsewhere 19, 21, 22. For example, Rahmani-
Neishaboor et al. 22 impregnated acetyl salicylic acid, as an anti-inflammatory agent, into 
carboxymethyl cellulose gel and applied topically to rabbit ear model wounds. They observed 
that topical application of such anti-inflammatory agent profoundly reduced epidermal 
proliferation and thickness. This resulted in reduced scar formation.   
 
3.2.4.4. Gene expression profile 
Scarless healing of wound requires a precise balance between ECM accumulation and 
degradation. In the late stage of skin wound healing, the majority of deposited collagens is 
collagen I. In remodeling phase, content, type and orientation of collagens are modified 5, 69, 70. 
The depositions of collagen I, III and IV in all the samples at 28 days post-treatment are 
presented in Figure 8a. The accumulations of all the examined collagen types were highest in 
the NTW as compared to other experimental groups. From the Immunohistochemistry staining, 
we observed that the collagens in the scar of the NTW groups arranged randomly. This indicates 
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that the NTW was not completely healed and needed more time to be remodeled. The content of 
the collagen in the animals receiving AM/ESF and AM/ESF/AMCSs seemed to be lower than in 
AM and AM/AT-MSCs treated wounds. On the other hand, the collagen depositions in all the 
treated wounds (G2-G5) showed to have a regular orientation. The collagen deposition over the 
wound in an irregular orientation during the first one week of post-wounding was observed in 
earlier studies. During remodeling phase, the collagens are degraded and re-arranged in a regular 
orientation 5, 22, 66, 69. All the Immunohistochemistry results reveal the positive effects of both 
ESF and AT-MSCs on decreasing the scar formation. 
As mentioned above, overexpression of collagen and subsequent collagen deposition is an 
important and reliable indicator of scar formation 23, 69, 71. The results indicated that the 
expressions of Col I, III and IV were significantly down-regulated in the implanted animals 
compared with NTW (Figure 8b). The animals treated with AM and NTW showed a significant 
up-regulation of Col I gene expression as compared to other experimental groups and NS. The 
expression of Col IV in the scar site of NTW was higher than those in other groups (p≤0.05). The 
expressions of Col I and IV were up-regulated in experimental groups G2 to G5. The difference 
was not significant when compared to NS. On the other hand, the expression of Col III in 
animals treated with AM and AM/ESF as well as NTW remained significantly up-regulated as 
compared to NS (p≤0.05). All the results revealed the effects of the AM/ESG grafting on down-
regulation of collagen gene expression. This leads to a conclusion that the scar formation was 
remarkably decreased. The presence of the AT-MSCs significantly decreased the scar formation 
through down-regulation of the collagen gene expression. It is reported that the AT-MSCs have 
anti-inflammatory properties through the secretion of several anti-inflammation factors 72, 
73.Spiekman et al. 42 demonstrated that adipose tissue-derived stromal cells prevented scar 
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through inhibition of TGF-β1–induced adverse differentiation of human dermal fibroblast in a 
paracrine fashion.  
To further understand how the AT-MSCs, ESF and AM reduce the scar formation, the 
expressions of TNF-α and TGF-β1 were compared between the experimental groups at 28 days 
of post-implantation. The expression of MIP-2, TNF-α and TGF-β1 in the animals implanted 
with AM and NTW remained significantly up-regulated when compared to untreated control 
(p≤0.05). In addition, expression of TNF-α in the AM/ESF group was significantly lower than in 
wound treated with AM (Figure 8b). 
The results of this study indicated that both AT-MSCs and ESF might assist in lowering of the 
scar formation through minimizing inflammatory response and subsequently decreased 
collagenesis. This was in agreement with a study that showed the effects of ginsenoside-Rg3-
loaded fibrous PLGA functionalized with bFGF growth factor on prevention of scar though a 
decrease of collagen deposition 21.  
Another important indicator of the scar formation is the presence of matrix metalloprotease 
(MMP) activity. MMPs are diverse proteolytic enzymes involved in remodeling phase through 
regulating the ECM composition. This facilitates cell migration and neovascularization 74. 
Rahmani-Neishaboor et al. 71 showed that stratifin, a keratinocyte specific 14-3-3 protein, 
modulated scar formation by inducing the expression of MMP-1 (collagenase) and subsequently 
reduced the matrix accumulation.  
In our study, the effects of ESF, AM and AT-MSCs on relative expression of MMP-1 
(collagenase) and MMP-2 (gelatinase) in scar were evaluated. All the wounds exhibited a 
significant increase in MMP-1 and MMP-2 expression compared to NS (P≤0.05). In addition, the 
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treated wounds (G2-G5) showed a relatively higher MMP-1 and MMP-2 expression in 
comparison with NTW (G1) (P≤0.05). Figure 8b shows a significant increase of MMP-1 and 
MMP-2 in AM/ESF treated group compared to AM group. It is reported that TGF-β suppress the 
expression of MMP-1 75. In our study, we observed that MMP-1 was up-regulated when the 
expression of TGF-β was decreased. Taken together all the different experimental results suggest 
that a combination of AM and ESF modulate scar formation by reducing chronic inflammatory 
response, collagen deposition and also induction of MMPs expression. 
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Figure 8. (a) Deposition of collagen types I, III and IV (COL I, III and IV) in scar tissues of all 
experimental groups using immunohistochemical staining. Collagens and cell nuclei were 
stained in brown and dark blue, respectively. (b) The mRNA relative expression of MMP-1, 
MMP-2, MIP-2, TNF-α, Collagen types I, III and IV, and TGF-β1 of the scars in all the groups at 
day 28 of post-operation. NS (Normal skin); G1: NTW (No treated wound) ; G2: AM; G3: 
AM/AT-MSCs; G4: AM/ESF; G5: AM/ESF/AT-MSCs. * indicates significant difference with 
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G1; ** indicates significant difference with NS. † indicates significant difference between G4 
and G2.   
 
4. CONCLUSION 
This study describes the skin burn wound healing potential of 3D bi-layered protein-based 
artificial skin alone and in combination with mesenchymal stem cells in vivo. Our data suggest 
that the 3D decellularized human amniotic membrane/electrospun nanofibrous silk fibroin 
artificial skin in combination with adipose tissue-derived mesenchymal stem cells accelerates 
significantly scarless wound healing as well as neo-vascularization and early re-epithelialization 
when implanted to 3rd degree burn wounds in mice. This also indicates that the presence of the 
electrospun nanofibrous silk fibroin has an important effect on the stem cells differentiation and 
subsequently facilitating wound healing. Preclinical wound therapy mice model also 
demonstrates a decreased accumulation of extracellular matrix via collagen deposition, and scar 
formation. Our fabricated biomaterial composite artificial skin prove both in vitro and in vivo 




SI Table 1: Recent key researches carried out on scarless healing of skin wounds 
SI Table 2: Mouse primers used in RT-PCR analysis 
SI Figure 1: H&Es and Masson’s Trichrome (MT) stained sections at day 28 post-operation.  
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AM: Amniotic membrane; AM/ESF: Amniotic membrane/electrospun silk fibroin; AT-MSCs: 
Adipose Tissue-derived mesenchymal stem cells; BC: Blood clot; COL: Collagen; ECs: 
Epithelial cells; ESF: Electrospun nanofibrous silk fibroin; ET: Ethanol-treated; ETI: Epidermal 
thickness index; EUT: Ethanol-untreated; HF: Hair Follicle; KCs: Keratinocyte cells; MSCs: 
Mesenchymal stem cells; MT: Masson’s trichrome;NS: Normal skin; NTW: Non-treated wound; 
PMN: Polymorphonuclear leukocytes; SEI: Scar elevation index; SF: Silk fibroin; G1: controls 
with 3rd degree burn wound and no implantation (NTW);  G2: 3rd degree burn wound implanted 
with AM alone;  G3: 3rd degree burn wound implanted with AM/AT-MSCs construct; G4: 3rd 
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